glp 1 as a pill New GLP-1 Foundayo (Orforglipron) Gets FDA Approval for Obesity This gentle FDA Approves Wegovy Alternative for

in nutritional physiology

Its superior clinical trial results led to a rapid surge in sales, challenging the established dominance of Novo Nordisk's semaglutide products (Ozempic/Wegovy)

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors

These medications slow gastric emptying and suppress appetite, which may reduce oral intake while increasing losses of sodium, potassium, magnesium, and other essential minerals

in Nutrients compiled clinical and experimental evidence demonstrating that hydroxytyrosol improves lipid profiles, glycaemia, and insulin sensitivity while counteracting oxidative and inflammatory processes (Peyrol et al., 2017)

Kim and Dr